Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
200 KIDNEY TRANSPLANTATION IN TUZLA
BOSNIA AND HERZEGOVINA
Enisa Mešić, UKC Tuzla
Nefrološka škola
Tešanj, 06.10.2018.
Tuzla
1990
2006
2016
FBIH - KIDNEY TRANSPLANTATION 2015-2018
6
10 0
4
0
21
10
12
1
8
5
7 76 6 6
44
8
23
1819
1514
0
2
4
6
8
10
12
14
16
18
20
2015 2016 2017 2018
Sarajevo
LRD
Sarajevo
KTx
Sarajevo
ukupno
Tuzla
LRD
Tuzla
URLD
Tuzla
Ktx
Tuzla
ukupno
1999
2006
0
20
40
60
80
100
120
140
160
1999-2005 2006-2012 2012-2018 1999-2018
LRD
URLD
KTx
KIDNEY TRANSPLANTATION IN TUZLA 1999-2018
LRD
68%
URLD
16%
Ktx
16%
1999-2018
LRD
98%
URLD
2%
Ktx
0%
1999-2005
LRD
69%
URLD
9%
Ktx
22%
2006-2012
LRD
48%
URLD
28%
Ktx
24%
2013-2018
14
2
12
1
Deceased donors
Tuzla Sarajevo Zenica Banja Luka
AGE AND GENDER STRUCTURE OF RECIPIENTS AND DONORS
Tuzla LRD URLD Deceased
Average age of
recipients
32.6 years (12-72) 47.4 (22-69) 36.4 years (26-68)
Female recipients 49 (36.0.3%) 10 (34.48%) 15 (42.86%)
Male recipients 87 (63.98%) 19 (65.52%) 20 (57.14%)
Dialysis 33 (1-264) months 42 (13-166) 70 (1-170)
Average age of donors
49.53 years (25-72) 47.52 (21-71) 48.06 (25-65)
LIVING RELATED AND UNRELATED DONORS
Tuzla LRD URLD
Mothers 46 (33.82%)
Fathers 33 (24.26%)
Sisters 24 (17.65%)
Brothers 23 (16.91%)
Others 10 (7.35%)
Wives 14 (48.28%)
Husbands 10 (34.48%)
Others 5 (17.24%)
12 younger than 18 years
PRIMARY KIDNEY DISEASE
51%
3%5%
11%
18%
12%
GN DM PN Reflux NN Ostalo
IMUNOSUPPRESIVE THERAPY
• 1999 – 2002• ATG + triple IS therapy (KS, azathioprine,
cyclosporin)
• 2002 – 2017 • Basiliximab + triple IS (KS, MMF, cyclosporin)
• 2006 – 2017• Tacrolimus 50% bolesnika• Advagraf (2016)
• 2011-2018• Generics
ACUTE REJECTION AND DELAYED GRAFT FUNCTION DURING THE FIRST POST-TRANSPLANTATION YEAR
Acute rejection Delayed graft function Primary graft afunction Normal graft function
Ktx (35) 4 6 2 19
URLD (29) 5 3 1 20
LRD (136) 17 5 4 110
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
LRD (136) URLD (29) Ktx (35)
EARLY SURGICAL COMPLICATIONS, INFECTIONS AND CARDIOVASCULAR INCIDENTS DURING THE FIRST POST-
TRANSPLANTATION YEAR
LRD (136) URLD (29) Ktx (35)
CVD 4 2 3
Infections 14 5 9
Early surgical complications 22 7 8
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Early surgical complications Infections CVD
HCV + RECIPIENTS
88%
6%6%
Ukupno
antiHCV +
Liječeni
17
5 YEARS OVERAL GRAFT AND PATIENTS SURVIVAL
0 02
16
1 1
76
5
9
LRD (92) URLD (6) Ktx (12)
0
10
20
30
40
50
60
70
80
Lethal outcome Dialysis Functioning graft
82,6%
83,3 %
75,0 %
Nedovoljno dobro
• Dijagnostika moždane smrti i broj organa od umrlih osoba
• Lista čekanja
• Federalni transplant centar
• Imunološka dijagnostika
• Organizacija transplantacije u BiH
DA
• Žive rodbinske transplantacije bubrega
• Žive nerodbinske transplantacije bubrega (rodbina i tazbina)
• Transplantacije bubrega u visoko-rizičnih i senzibiliziranih bolesnika
• Transplantacije bubrega od umrlih osoba
• Besplatno za osiguranike u FBIH
NE
• ABO inkompatibilne transplantacije bubrega
• Altruistični donori
• Uparene transplantacije
Tuzla
1999 - 2019